Histone H3F3/H3.3 chaperone DAXX converts to modulate SQSTM1 phase condensation for NFE2L2 activation
dc.contributor.author | Yang, Y | |
dc.contributor.author | Valionyte, E | |
dc.contributor.author | Kelly, J | |
dc.contributor.author | Luo, S | |
dc.date.accessioned | 2024-05-01T10:31:42Z | |
dc.date.available | 2024-05-01T10:31:42Z | |
dc.date.issued | 2020-01-02 | |
dc.identifier.issn | 1554-8627 | |
dc.identifier.issn | 1554-8635 | |
dc.identifier.uri | https://pearl.plymouth.ac.uk/handle/10026.1/22377 | |
dc.description.abstract |
Macroautophagy/autophagy cargo receptor SQSTM1/p62 puncta or clustering formation is critical for its function in cargo recognition and LC3 interaction. Evidence suggests that SQSTM1 puncta formation is a process of liquid-liquid phase separation. It is poorly understood how SQSTM1 liquid-liquid phase separation is regulated. We found that cytoplasmic DAXX enhances SQSTM1 puncta formation, and further demonstrated that DAXX drives SQSTM1 liquid phase condensation through increasing SQSTM1 oligomerization. DAXX promotes SQSTM1 recruitment of KEAP1, subsequently activating an NFE2L2/NRF2-mediated stress response. This study suggests a new mechanism of SQSTM1 phase condensation by a protein-protein interaction, and indicates that cytoplasmic DAXX can play a role to regulate redox homeostasis. | |
dc.format.extent | 171-172 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.publisher | Informa UK Limited | |
dc.subject | Autophagy | |
dc.subject | DAXX | |
dc.subject | phase condensation | |
dc.subject | selective autophagy | |
dc.subject | SQSTM1 | |
dc.title | Histone H3F3/H3.3 chaperone DAXX converts to modulate SQSTM1 phase condensation for NFE2L2 activation | |
dc.type | journal-article | |
dc.type | Editorial Material | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/31607206 | |
plymouth.issue | 1 | |
plymouth.volume | 16 | |
plymouth.publisher-url | http://dx.doi.org/10.1080/15548627.2019.1677323 | |
plymouth.publication-status | Published | |
plymouth.journal | Autophagy | |
dc.identifier.doi | 10.1080/15548627.2019.1677323 | |
plymouth.organisational-group | |Plymouth | |
plymouth.organisational-group | |Plymouth|Research Groups | |
plymouth.organisational-group | |Plymouth|Faculty of Health | |
plymouth.organisational-group | |Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | |Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CBR | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA | |
plymouth.organisational-group | |Plymouth|Users by role | |
plymouth.organisational-group | |Plymouth|Users by role|Current Academic staff | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine | |
plymouth.organisational-group | |Plymouth|Faculty of Health|Peninsula Medical School | |
plymouth.organisational-group | |Plymouth|Users by role|Researchers in ResearchFish submission | |
plymouth.organisational-group | |Plymouth|REF 2029 Researchers by UoA | |
plymouth.organisational-group | |Plymouth|REF 2029 Researchers by UoA|UoA01 Clinical Medicine | |
dc.publisher.place | United States | |
dc.date.updated | 2024-05-01T10:31:41Z | |
dc.identifier.eissn | 1554-8635 | |
dc.rights.embargoperiod | forever | |
rioxxterms.versionofrecord | 10.1080/15548627.2019.1677323 |